BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark GRC, Strachan JA, McPherson A, Digby J, Mowat C, Steele RJC, Fraser CG. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies. Clin Chem Lab Med 2020;58:2073-80. [PMID: 32324157 DOI: 10.1515/cclm-2020-0268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Libby G, Barnett KN, Fraser CG, Steele RJC. Association between faecal occult bleeding and medicines prescribed for chronic disease: a data linkage study. J Clin Pathol 2021;74:664-7. [PMID: 33051288 DOI: 10.1136/jclinpath-2020-206986] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pin-Vieito N, García Nimo L, Bujanda L, Román Alonso B, Gutierrez-Stampa MÁ, Aguilar-Gama V, Portillo I, Cubiella J. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. United European Gastroenterol J 2021;9:256-67. [PMID: 32778002 DOI: 10.1177/2050640620949714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
3 Fraser CG, Benton SC. Faecal haemoglobin examinations have come of age, but further maturation seems desirable. Ann Clin Biochem 2022;59:97-100. [PMID: 35060392 DOI: 10.1177/00045632211063459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Clark GR, Steele RJ, Fraser CG. Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening. Clinical Chemistry and Laboratory Medicine (CCLM) 2022;0. [DOI: 10.1515/cclm-2022-0583] [Reference Citation Analysis]
5 Barnett KN, Clark GRC, Steele RJC, Fraser CG. Faecal Haemoglobin Estimated by Faecal Immunochemical Tests-An Indicator of Systemic Inflammation with Real Clinical Potential. Diagnostics (Basel) 2021;11:2093. [PMID: 34829442 DOI: 10.3390/diagnostics11112093] [Reference Citation Analysis]
6 Benton SC, Piggott C, Blyuss O, Li SJ, Mathews C, Carroll M, Duffy S. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England. J Med Screen 2021;:9691413211013376. [PMID: 33983066 DOI: 10.1177/09691413211013376] [Reference Citation Analysis]
7 McSorley ST, Digby J, Clyde D, Cruickshank N, Burton P, Barker L, Strachan JA, Fraser CG, Smith K, Mowat C, Winter J, Steele RJC. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care. Colorectal Dis 2021;23:1615-21. [PMID: 33064898 DOI: 10.1111/codi.15405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Clark GR, Digby J, Fraser CG, Strachan JA, Steele RJ. Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme. J Med Screen 2021;:9691413211056970. [PMID: 34806935 DOI: 10.1177/09691413211056970] [Reference Citation Analysis]
9 Johnstone MS, Miller G, Pang G, Burton P, Kourounis G, Winter J, Crighton E, Mansouri D, Witherspoon P, Smith K, McSorley ST. Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients. Ann Clin Biochem 2022;:45632221076771. [PMID: 35044264 DOI: 10.1177/00045632221076771] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li SJ, Sharples LD, Benton SC, Blyuss O, Mathews C, Sasieni P, Duffy SW. Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies. J Med Screen 2021;28:277-85. [PMID: 33342370 DOI: 10.1177/0969141320980501] [Reference Citation Analysis]
11 Clark GR, Fraser CG, Strachan JA, Steele RJ. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme. J Med Screen 2022;:9691413221110012. [PMID: 35747907 DOI: 10.1177/09691413221110012] [Reference Citation Analysis]
12 Jain S, Maque J, Galoosian A, Osuna-Garcia A, May FP. Optimal Strategies for Colorectal Cancer Screening. Curr Treat Options Oncol 2022. [PMID: 35316477 DOI: 10.1007/s11864-022-00962-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li J, Qiu Z, Deng Y, Li Y, Lin Z, Wu Y, Weng F, Tian H, Ou Q, Gong C, Pan Z, Wan D, Peng J, Fang Y. Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00463-8] [Reference Citation Analysis]
14 Fraser CG. Assuring the quality of examinations using faecal immunochemical tests for haemoglobin (FIT). Clin Chem Lab Med 2020;59:245-7. [PMID: 33079702 DOI: 10.1515/cclm-2020-1509] [Reference Citation Analysis]